May 25th 2023
Click here to answer this week's poll.
Harnessing the Immune System to Fight Basal Cell Carcinoma: What are the Risks?
January 4th 2023In basal cell carcinoma, the most common type of skin cancer accounting for 80% of all non-melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with Hedgehog pathway inhibitors.